Navigation Links
Leak Detection Associates Announces New & Updated Helium Leak Detection System

Leak Detection Associates (LDA), the world’s premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited to announce the launch of its newest and most advanced helium leak detection system, the SIMS Model 1915+. The SIMS 1915+ unit is engineered incorporating industry-leading Agilent Technologies components and is custom designed to meet the stringent requirements of clients in FDA-regulated industries. The new unit will replace the SIMS 1284+, marketed by LDA for the past 12+ years, and represents the most advanced and sensitive system available worldwide. With a revised interface and corresponding pump configuration specifically intended for pharma/biotech package testing, clients will see an improvement in instrument performance with more intuitive operation. Notably, the launch of the system coincides with the release of the all-new 21 CFR Part 11 compliant software package developed by the Leak Detection Associates software development team.

“While the SIMS 1284+ has proven to be a workhorse with a global client installation base for over 12 years, advancements in vacuum and helium-based technology have enabled our engineering team to improve component configuration and system performance, yielding the most advanced helium leak testing system for pharmaceutical and biotechnology applications. I am confident our clients will appreciate the new features, capabilities, and usability the SIMS 1915+ will offer”, commented Jeff Morrow Lucas Director of Engineering for Leak Detection Associates.

Key features and benefits of the new SIMS 1915+ model include:

  • Base Helium Leak Detector powered by Agilent Technologies, globally recognized as a leader in the regulated market industries for laboratory equipment
  • An IDP-15 Dry vacuum pump (oil free) rated for 15m3/hour (9 cfm) and a Patented dual pump design for fast clean up and background suppression
  • Improved power-off process keeps spectrometer under vacuum and protects the turbomolecular pump, reducing operator dependency and increasing filament longevity
  • Maximum Test Port Pressure of 13 mbar (10 Torr, 1333 Pa) and 200 mbar (150 Torr, 2000 Pa) in Gross Leak Mode

The new SIMS Model 1915+ model is available for immediate order and based upon an improved supplier relationship with Agilent Technologies, lead times for custom-built orders will decrease from the previous 12-14 weeks to as short as 4 weeks. As clients have come to expect, each new SIMS Model 1915+ will be customized to client’s specific testing needs whether testing vials, blister cards, cartridges, or pre-filled syringes. Each SIMS 1915+ can be complimented with Leak Detection Associates’ robust service and contract offerings to provide end-to-end leak testing solutions.

About Leak Detection Associates, LLC
For over 20 years, Leak Detection Associates has been the premier manufacturer of custom helium leak detection instruments for the pharmaceutical, biotechnology, medical device and food packaging industries. LDA's well-established technology has been incorporated into ASTM and compendia guidance documents. This robust industry experience, combined with the advanced capabilities of its newest model the SIMS 1915+ helium leak detection unit, provides companies with tools to quantitatively evaluate leakage, improve the package development cycle, establish manufacturing controls, and ultimately reduce risk to the product and consumer throughout the lifecycle.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. LiquiTech and Spartan Bioscience Partner to Bring Innovative, Real-time Legionella Detection to Health Care Sector
2. Leak Detection Associates Announces Global Expansion – Signs Partnership Agreement with IPP Group for England and Ireland
3. Leak Detection Associates Announces Expansion of a New State of the Art Manufacturing Facility
4. CRISPR-Chip Enables Digital Detection of DNA without Amplification
5. Leak Detection Associates Announces Participation in INTERPHEX 2019
6. How to Leverage Real World Data to Achieve Faster Insights for Better Adverse Event Detection and Reporting, New Webinar Hosted by Xtalks
7. Bruker Features the Use of Nuclear Magnetic Resonance for Early disease detection in Educational Webinar
8. Crossmatch Awarded $5.8 Million IARPA Contract to Develop Next-Gen Biometric Presentation Attack Detection Technologies
9. Emotion Detection and Recognition Market Worth 36.07 Billion USD by 2021
10. Global Emotion Detection and Recognition Market 2016-2020 - Market to Reach USD 22.65 Billion
11. Emotion Detection and Recognition Market worth 22.65 Billion USD by 2020
Post Your Comments:
(Date:11/27/2019)... ... , ... The MyOnyx rehab solution by Thought ... measure and display muscle activity in real time. This information helps the physical ... patient and therapist can see when exercises are performed correctly and efficiently. , ...
(Date:11/19/2019)... ... 19, 2019 , ... The inaugural Cell & Gene Therapy Day takes place ... one-day event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene ... “We are witnessing significant innovation in cell and gene therapies, and we are at ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... in the design and manufacturer of technical ergonomic seating solutions, announced this ... compliant with Healthier Hospital Initiative guidelines. Established by Practice Greenhealth, a health ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... ... December 04, 2019 , ... Improved Pharma’s analytical methods ... materials. Additionally, their PDF Synchrotron methods provide a way to determine the structure ... in regulatory and patent applications.  , The latest developments were recently shared at ...
(Date:11/22/2019)... , ... November 22, 2019 ... ... engineering firm, hosted a live webinar covering a step-by-step cold chain validation ... antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry leaders, ...
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL Inc. a ... selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its ... points using panels of unique and genetically edited cell lines from various tumors. ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... to educate Americans about the deadly healthcare-associated infection C. diff. The campaign, ... of the epidemic, which kills at least 30,000 people in the U.S. each ...
Breaking Biology Technology: